Evidence map›Paper›PMID 32617694›Full record

Observational studyEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Decreased duration of intravenous cephalosporins in intensive care unit patients with selective digestive decontamination: a retrospective before-and-after study.

Calypso Mathieu, Roberta Abbate, Zoe Meresse, Emmanuelle Hammad, Gary Duclos, François Antonini, Nadim Cassir, Jeroen Schouten, Laurent Zieleskiewicz, Marc Leone

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 4 countries.

Calypso MathieuAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
Roberta AbbateAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
Zoe MeresseAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
Emmanuelle HammadAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
Gary DuclosAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
François AntoniniAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
Nadim CassirMEPHI, IHU Méditerranée Infection, Aix-Marseille Université, Marseille, France.
Jeroen SchoutenDepartment of Intensive Care, Radboudumc, Netherlands.
Laurent ZieleskiewiczAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France.
Marc LeoneAix Marseille University, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d'anesthésie et de réanimation, Marseille, France. marc.leone@ap-hm.fr.ORCID http://orcid.org/0000-0002-3097-758X
Aix-Marseille Université · FRRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective digestive decontamination (SDD) reduces the rate of infection and improves the outcomes of patients admitted to an intensive care unit (ICU). A risk associated with its use is the development of multi-drug-resistant organisms. We hypothesized that a 1-day reduction in systemic antimicrobial exposure in the SDD regimen would not affect the outcomes of our patients. In this before-and-after study design, 199 patients and 248 patients were included in a 3-day SDD group and a 2-day SDD group, respectively. The rates of hospital-acquired pneumonia and ICU infections were similar in both groups. The rates of bloodstream infection and bacteriuria were significantly lower in the 2-day SDD group than in the 3-day SDD group. Compared with the patients in the 3-day group, the patients in the 2-day SDD group received fewer antibiotics and less exposure to mechanical ventilation, and they used fewer ICU resources. The rates of ICU mortality and 28-day mortality were similar in both groups. The incidence of multi-drug-resistant organisms was similar in both groups. Within the limitations inherent to our study design, reducing the exposure of prophylactic systemic antibiotics in the SDD setting from 3 days to 2 days was not associated with impaired outcomes. Future randomized controlled trials should be conducted to test this hypothesis and investigate the effects on the development of multi-drug resistant organisms.

Indexed as

AdultAnti-Bacterial AgentsBacteremiaCephalosporinsDrug Administration ScheduleFemaleFranceGastrointestinal TractHospitals, UniversityHumansInfusions, IntravenousIntensive Care UnitsMaleRetrospective StudiesAnti-Bacterial AgentsCephalosporinsAntibioticDecontaminationInfectionProphylaxisSelective

Identifiers

PMID32617694
PMCPMC7330883
OpenAlexW3039305012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.